The translocation marked B, t(2;5)(p23;q35), fuses the NPM1 gene on chromosome 5q35 to the ALK gene on chromosome 2p23, creating the NPM1-ALK fusion protein. This fusion protein is a constitutively active tyrosine kinase that drives oncogenic signaling through STAT3, PI3K-AKT, and RAS-MAPK pathways—the defining molecular hallmark of ALK-positive anaplastic large cell lymphoma. The cytoplasmic and nuclear ALK staining pattern (due to NPM1's nuclear shuttling function) is pathognomonic for this translocation. (Robbins Basic Pathology 11e; WHO Classification 5e)
Robbins Basic Pathology 11e (Hematopoietic Neoplasms); WHO Classification of Tumors of Haematopoietic and Lymphoid Tissues 5e
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.